| # | Drug | Count |
|---|---|---|
| 0 | ISOTRETINOIN | 5252 |
| 1 | ADALIMUMAB | 779 |
| 2 | INFLIXIMAB | 549 |
| 3 | SECUKINUMAB | 470 |
| 4 | PREDNISONE | 459 |
| 5 | VEDOLIZUMAB | 370 |
| 6 | METHOTREXATE SODIUM | 365 |
| 7 | METHOTREXATE | 321 |
| 8 | ADALIMUMAB-ADAZ | 305 |
| 9 | ADALIMUMAB-FKJP | 288 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ERYTHROMYCIN AND BENZOYL PEROXIDE | 18 | 0.1111 |
| 1 | ISOTRETINOIN | 5252 | 0.1068 |
| 2 | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0256 |
| 3 | DEXBROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE | 2 | 0.0247 |
| 4 | 5-HYDROXYTRYPTOPHAN | 1 | 0.0189 |
| 5 | OLSALAZINE SODIUM | 3 | 0.0152 |
| 6 | ALOGLIPTIN AND METFORMIN HYDROCHLORIDE | 2 | 0.0145 |
| 7 | TAZAROTENE | 14 | 0.0120 |
| 8 | OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE | 77 | 0.0104 |
| 9 | AZATHIOPRINE SODIUM | 26 | 0.0104 |
| # | Drug class | Count |
|---|---|---|
| 0 | Retinoid [EPC] | 5282 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 1086 |
| 2 | Corticosteroid [EPC] | 754 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 615 |
| 4 | Interleukin-17A Antagonist [EPC] | 588 |
| 5 | Integrin Receptor Antagonist [EPC] | 380 |
| 6 | Interleukin-23 Antagonist [EPC] | 330 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 318 |
| 8 | Aminosalicylate [EPC] | 313 |
| 9 | Interleukin-12 Antagonist [EPC] | 255 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Retinoid [EPC] | 5282 | 0.0214 |
| 1 | Human Blood Coagulation Factor [EPC] | 2 | 0.0060 |
| 2 | Tricyclic Antidepressant [EPC] | 2 | 0.0042 |
| 3 | Interleukin-17 Receptor A Antagonist [EPC] | 7 | 0.0035 |
| 4 | Tubulin Inhibiting Agent [EPC] | 1 | 0.0035 |
| 5 | Serotonin-4 Receptor Agonist [EPC] | 2 | 0.0032 |
| 6 | Interleukin-17A Antagonist [EPC] | 588 | 0.0030 |
| 7 | Interleukin-12 Antagonist [EPC] | 255 | 0.0025 |
| 8 | Aminosalicylate [EPC] | 313 | 0.0024 |
| 9 | Bismuth [EPC] | 12 | 0.0021 |